ATE36652T1 - Verfahren zur herstellung von mikrokapseln zur intraversalen verabreichung. - Google Patents

Verfahren zur herstellung von mikrokapseln zur intraversalen verabreichung.

Info

Publication number
ATE36652T1
ATE36652T1 AT84112959T AT84112959T ATE36652T1 AT E36652 T1 ATE36652 T1 AT E36652T1 AT 84112959 T AT84112959 T AT 84112959T AT 84112959 T AT84112959 T AT 84112959T AT E36652 T1 ATE36652 T1 AT E36652T1
Authority
AT
Austria
Prior art keywords
intraversal
microcapsules
administration
manufacture
encapsulation
Prior art date
Application number
AT84112959T
Other languages
English (en)
Inventor
Benjamin Mosier
Original Assignee
Benjamin Mosier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benjamin Mosier filed Critical Benjamin Mosier
Application granted granted Critical
Publication of ATE36652T1 publication Critical patent/ATE36652T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
    • B01J13/125—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution by evaporation of the solvent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
AT84112959T 1983-11-15 1984-10-26 Verfahren zur herstellung von mikrokapseln zur intraversalen verabreichung. ATE36652T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/552,160 US4492720A (en) 1983-11-15 1983-11-15 Method of preparing microspheres for intravascular delivery
EP84112959A EP0142085B1 (de) 1983-11-15 1984-10-26 Verfahren zur Herstellung von Mikrokapseln zur intraversalen Verabreichung

Publications (1)

Publication Number Publication Date
ATE36652T1 true ATE36652T1 (de) 1988-09-15

Family

ID=24204175

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84112959T ATE36652T1 (de) 1983-11-15 1984-10-26 Verfahren zur herstellung von mikrokapseln zur intraversalen verabreichung.

Country Status (6)

Country Link
US (1) US4492720A (de)
EP (1) EP0142085B1 (de)
JP (1) JPS60116627A (de)
AT (1) ATE36652T1 (de)
CA (1) CA1220098A (de)
DE (1) DE3473567D1 (de)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE93384T1 (de) * 1983-11-14 1993-09-15 Univ Kentucky Res Found Poroese mikrokugeln zur arzneistoffabgabe sowie verfahren zu deren herstellung.
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4680171A (en) * 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
US4683092A (en) * 1985-07-03 1987-07-28 Damon Biotech, Inc. Capsule loading technique
US4709703A (en) * 1985-11-12 1987-12-01 Mayo Foundation Imaging system and method using radiopaque microspheres for evaluation of organ tissue perfusion
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
FR2634397B2 (fr) * 1986-12-31 1991-04-19 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une proteine sous forme de nanoparticules
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US5082723A (en) * 1989-09-27 1992-01-21 Kimberly-Clark Corporation Osmotically enhanced absorbent structures
EP0550436A1 (de) * 1989-11-06 1993-07-14 Alkermes Controlled Therapeutics, Inc. Proteinmikrosphären und verfahren zu deren verwendung
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
US5221535A (en) * 1989-11-13 1993-06-22 Nova Pharmaceutical Corporation Sustained release formulations of insect repellent
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
US5478564A (en) * 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
DE4010400C1 (de) * 1990-03-31 1991-05-29 Fried. Krupp Gmbh, 4300 Essen, De
US5091187A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
FR2663538A1 (fr) * 1990-06-26 1991-12-27 Cird Galderma Procede de preparation de microspheres de corps gras chargees ou non chargees en une substance active.
US5484584A (en) * 1990-10-02 1996-01-16 Board Of Regents, The University Of Texas System Therapeutic and diagnostic use of modified polymeric microcapsules
US5238714A (en) * 1990-10-02 1993-08-24 Board Of Regents, The University Of Texas System Efficient microcapsule preparation and method of use
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
US5171217A (en) * 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors
US6387399B1 (en) * 1994-12-02 2002-05-14 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microencapsulated bioactive agents and method of making
US5827531A (en) * 1994-12-02 1998-10-27 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microcapsules and methods for making
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery
ATE386506T1 (de) * 1995-10-17 2008-03-15 Jagotec Ag Verabreichung unlöslicher arzneistoffe
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
EP1054678B1 (de) * 1998-02-11 2003-05-28 RTP Pharma Corporation Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ES2216517T3 (es) 1998-05-29 2004-10-16 Skyepharma Canada Inc. Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor.
IL141095A0 (en) 1998-08-19 2002-02-10 Rtp Pharma Inc Injectable aqueous dispersions of propofol
AU767154B2 (en) * 1998-11-20 2003-10-30 Skyepharma Canada Inc. Dispersible phospholipid stabilized microparticles
EP1214059B1 (de) * 1999-09-21 2005-05-25 Skyepharma Canada Inc. Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
IL152180A0 (en) * 2000-04-10 2003-05-29 Teva Pharma Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
ES2469642T3 (es) 2000-04-20 2014-06-18 Jagotec Ag Procedimiento mejorado para partículas de fármaco insoluble en agua
CN100457090C (zh) 2000-08-31 2009-02-04 斯凯伊药品加拿大公司 磨制颗粒
TWI354568B (en) * 2000-09-20 2011-12-21 Jagotec Ag Insoluble drug particle compositions with improved
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
EP1361867B1 (de) * 2001-02-22 2007-03-21 Jagotec AG Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
US7094369B2 (en) * 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7462366B2 (en) * 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7131997B2 (en) * 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7053134B2 (en) * 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
WO2003105917A2 (en) * 2002-06-12 2003-12-24 Scimed Life Systems, Inc. Bulking agents
US7842377B2 (en) * 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7449236B2 (en) * 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) * 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7588825B2 (en) * 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7883490B2 (en) * 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
CA2513483C (en) * 2003-01-17 2011-11-29 Cornell Research Foundation, Inc. Injectable hydrogel microspheres from aqueous two-phase system
US7976823B2 (en) * 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) * 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) * 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US20050238870A1 (en) * 2004-04-22 2005-10-27 Marcia Buiser Embolization
US7311861B2 (en) * 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8425550B2 (en) * 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7727555B2 (en) * 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) * 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) * 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US20070004973A1 (en) * 2005-06-15 2007-01-04 Tan Sharon M L Tissue treatment methods
US9463426B2 (en) * 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US20070083219A1 (en) * 2005-10-12 2007-04-12 Buiser Marcia S Embolic coil introducer sheath locking mechanisms
US8007509B2 (en) * 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) * 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US20070142859A1 (en) * 2005-12-19 2007-06-21 Boston Scientific Scimed, Inc. Embolic coils
US7947368B2 (en) * 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US7501179B2 (en) * 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
US20070142560A1 (en) * 2005-12-21 2007-06-21 Young-Ho Song Block copolymer particles
US20070299461A1 (en) * 2006-06-21 2007-12-27 Boston Scientific Scimed, Inc. Embolic coils and related components, systems, and methods
US8414927B2 (en) * 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US20080145658A1 (en) * 2006-12-15 2008-06-19 Boston Scientific Scimed, Inc. Freeze Thaw Methods For Making Polymer Particles
KR100817906B1 (ko) * 2007-05-03 2008-03-31 현대로템 주식회사 철도 차량을 위한 비상 탈출용 램프
US9504274B2 (en) * 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
US10071181B1 (en) 2015-04-17 2018-09-11 Teleflex Innovations S.À.R.L. Resorbable embolization spheres

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880991A (en) * 1969-03-24 1975-04-29 Brook David E Polymeric article for dispensing drugs
JPS528795B2 (de) * 1971-12-30 1977-03-11
US4187194A (en) * 1972-01-03 1980-02-05 Xerox Corporation Encapsulation process
JPS523342B2 (de) * 1972-01-26 1977-01-27
US4016099A (en) * 1972-03-27 1977-04-05 Xerox Corporation Method of forming encapsulated toner particles
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4230687A (en) * 1978-05-30 1980-10-28 Griffith Laboratories U.S.A., Inc. Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process

Also Published As

Publication number Publication date
US4492720A (en) 1985-01-08
DE3473567D1 (en) 1988-09-29
CA1220098A (en) 1987-04-07
JPS60116627A (ja) 1985-06-24
EP0142085A2 (de) 1985-05-22
EP0142085B1 (de) 1988-08-24
EP0142085A3 (en) 1985-09-25

Similar Documents

Publication Publication Date Title
ATE36652T1 (de) Verfahren zur herstellung von mikrokapseln zur intraversalen verabreichung.
JPS5231981A (en) Microcapsule preparation method
AT384557B (de) Verfahren zur herstellung von einen wirkstoff enthaltenden mikrokapseln und die danach erhaeltlichen mikrokapseln
DK285088A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat i mikrokapselform samt saaledes fremstillet praeparat
ATE15798T1 (de) Heterozyklische carboxamide, zubereitungen, die solche verbindungen enthalten, verfahren zu ihrer herstellung und methoden zur behandlung damit.
ATE124606T1 (de) Verbessertes verfahren zur herstellung von mikrokapseln und verbesserte produkte.
ES2084698T3 (es) Procedimiento de encapsulacion.
JPS56161833A (en) Preparation of microcapsule in liquid vehicle
IT1214629B (it) Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
ATE83151T1 (de) Zellmembranproteine, zubereitungen, die sie enthalten und verfahren zu ihrer herstellung.
DE3784391D1 (de) Verfahren zur herstellung von eine oelloesliche substanz enthaltenden festen produkten.
CA1022288A (en) Clear perfumed polyamide resin and method of preparing it
ATE60711T1 (de) Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
ATE77052T1 (de) Verfahren zur herstellung von etofibrat oder aehnliche verbindungen enthaltende mikrogranula mit verzoegerter freisetzung sowie die auf diese weise erhaltenen produkte.
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
PT66756B (de) 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin dessen saureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
BR0211706A (pt) Método para encapsular um produto para fazer cápsulas, cápsula, e, método para produzir um alimento lìquido para organismos aquáticos e para tratar uma cápsula
ATE12458T1 (de) Verfahren zum fuellen von hartkapseln mit pharmazeutischen produkten, die phospholipide enthalten und bei zimmertemperatur hochviskos sind.
DE3856530D1 (de) Gerät zur Behandlung von pulverförmigem, granuliertem und konglomeriertem Material mit zugehörigem Analyseverfahren
DE59007027D1 (de) Verfahren zur Herstellung von Urethangruppen aufweisenden Polyharnstoff-Elastomeren.
AT382797B (de) Verfahren zur thermischen behandlung von pulver- foermigen und granulatartigen katalysatoren und dergleichen
MX9702361A (es) Agentes protectores de plantas microencapsulados, un procedimiento para su preparacion y su uso.
JPH069650B2 (ja) 徐放性マイクロカプセルの製造法
EP0124911A3 (en) 4-oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them
DE3869337D1 (de) Kapsel und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties